Lund Melanoma Study Group
1 – 10 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Systemic and local decorin levels mirror the clinical course of pancreatic cancer
- Contribution to journal › Article
-
Mark
Modeling anti-tumor immune responses using patient-derived melanoma organoids
- Contribution to journal › Article
-
Mark
Image enhancements by CLAHE and gamma correction do not improve diagnostic accuracy in teledermoscopy: a retrospective cohort study
- Contribution to journal › Article
- 2025
-
Mark
An Activin Receptor-Like Kinase 1-governed monocytic lineage shapes an immunosuppressive landscape in breast cancer metastases
- Contribution to journal › Article
-
Mark
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity
- Contribution to journal › Article
-
Mark
Teledermoscopic triage of melanoma-suspicious skin lesions is safe : A retrospective comparative diagnostic accuracy study with multiple assessors
- Contribution to journal › Article
-
Mark
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
- Contribution to journal › Article
-
Mark
Does tattoo exposure increase the risk of cutaneous melanoma? A population-based case-control study
- Contribution to journal › Article
-
Mark
Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma : A Nationwide Population-Based Registry Study from Sweden
(2025) In The British journal of dermatology
- Contribution to journal › Article
-
Mark
Antihypertensive Medication as a Risk Factor For Basal Cell Carcinoma : A Nationwide Registry-based Case-control Study
- Contribution to journal › Article
